+25.7%
EMR vs INCY
+20.6%
+5.1%
-23.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | INCY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | +4.5% | -2.0% | +1.9% |
| 7D | +1.6% | +5.1% | -3.5% | +1.0% |
| 30D | +5.0% | +7.6% | -2.6% | +4.0% |
| 3M | +7.7% | +1.9% | +5.8% | +7.3% |
| 6M | +26.8% | +26.5% | +0.3% | +20.4% |
| YTD | +29.9% | +24.4% | +5.5% | +22.1% |
| 1Y | +25.7% | +19.4% | +6.3% | +17.7% |
| All | +25.7% | +20.6% | +5.1% | +17.7% |
Cumulative growth
Daily Returns
Daily percentage return beside INCY.
Daily Out/Under-Performance
Portfolio return minus INCY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INCY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded INCY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling